Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Single-Dose Radiation Effective for Cutaneous T-Cell Lymphoma
Uncategorized

Single-Dose Radiation Effective for Cutaneous T-Cell Lymphoma

By Roger AndersonJun 19, 2013
Share
Facebook Twitter Email
Bharat Mittal, MD, chair of radiation oncology, began a study more than a decade ago to evaluate the efficacy of single-dose radiation therapy treatment for skin lesions caused by cutaneous T-cell lymphoma.

Why use 10 treatments when the same results can be achieved with one? 

That was the question Bharat Mittal, MD, chair of radiation oncology, posed more than a decade ago as he began evaluating the way people with cutaneous T-cell lymphoma (CTCL) were treated with palliative care. 

“Traditional methods meant that these patients had to return over and over and over again. What we found is that the results of a single, higher-dose radiation treatment were similar to the results of giving 10-15 treatments,” said Mittal, who recently published the work in the International Journal of Radiation Oncology, Biology, Physics. “What truly instigated this project was the burden and inconvenience that patients were experiencing from the standard treatment regimen.” 

CTCL is a rare type of cancer that begins in the white blood cells and attacks the skin, often causing rash-like skin redness and sometimes skin tumors. There is no cure for the disease, but palliative treatments can remove lesions and relieve pain. 

“The outcomes were excellent and we did a cost analysis and found that there was a savings of more than 200 percent when using just one treatment,” said Mittal, a member of The Robert H. Lurie Comprehensive Cancer Center of Northwestern University. “There’s no downside to it; patients experience reduced social and financial burden while dedicating less time and receiving comparative results.”

Today, single-treatment radiation therapy is the standard of care at Northwestern Memorial Hospital, and Mittal is optimistic about its implementation across the country. 

“At a national level, if this is adopted, there will be a great benefit to patients,” said Mittal, who published the paper with the help of former resident Tarita Thomas, MD, PhD, FSM’07, GME’12, and former undergraduate lab assistant Priya Agrawal WCAS’10. “I think we have accumulated some pretty solid evidence regarding this treatment option, but these tumors, in general, need a lot of additional research, some of which is taking place right here in the Department of Dermatology.”

Patient Care Research
Share. Facebook Twitter Email

Related Posts

Self-Powered Wireless Implant Delivers Medication, Then Dissolves

Mar 30, 2023
Mar 29, 2023

Adolescent Sexual Health Program Receives Funding for Social Marketing Campaign

Mar 29, 2023

The Future of IgE-Mediated Allergy Research and Treatments

Mar 29, 2023

Comments are closed.

Latest News

NUDOCS Program Inspires the Next Generation of Physicians

Mar 31, 2023

Women in Medicine Conference Celebrates Community

Mar 31, 2023

Self-Powered Wireless Implant Delivers Medication, Then Dissolves

Mar 30, 2023

Adolescent Sexual Health Program Receives Funding for Social Marketing Campaign

Mar 29, 2023

The Future of IgE-Mediated Allergy Research and Treatments

Mar 29, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230317_NM651
20230317_NM610
20230317_NM569
20230317_NM537
20230317_NM331
20230317_NM323
20230317_NM316
20230317_NM336
20230317_NM626
20230317_NM662
20230317_NM655
20230317_NM642

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.